Signals mediated by transforming growth factor-β initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease (original) (raw)

• Bettelli, E. et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441, 235–238 (2006).
  Article CAS Google Scholar
• Billiau, A. & Matthys, P. Modes of action of Freund's adjuvants in experimental models of autoimmune diseases. J. Leukoc. Biol. 70, 849–860 (2001).
  CAS PubMed Google Scholar
• Ferber, I.A. et al. Mice with a disrupted IFN-γ gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J. Immunol. 156, 5–7 (1996).
  CAS PubMed Google Scholar
• Willenborg, D.O., Fordham, S.A., Staykova, M.A., Ramshaw, I.A. & Cowden, W.B. IFN-γ is critical to the control of murine autoimmune encephalomyelitis and regulates both in the periphery and in the target tissue: a possible role for nitric oxide. J. Immunol. 163, 5278–5286 (1999).
  CAS PubMed Google Scholar
• Becher, B., Durell, B.G. & Noelle, R.J. Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12. J. Clin. Invest. 110, 493–497 (2002).
  Article CAS Google Scholar
• Gran, B. et al. IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination. J. Immunol. 169, 7104–7110 (2002).
  Article CAS Google Scholar
• Zhang, G.X. et al. Induction of experimental autoimmune encephalomyelitis in IL-12 receptor-β2-deficient mice: IL-12 responsiveness is not required in the pathogenesis of inflammatory demyelination in the central nervous system. J. Immunol. 170, 2153–2160 (2003).
  Article CAS Google Scholar
• Gutcher, I., Urich, E., Wolter, K., Prinz, M. & Becher, B. Interleukin 18-dependent engagement of interleukin 18 receptor-α is required for autoimmune inflammation. Nat. Immunol. 7, 946–953 (2006).
  Article CAS Google Scholar
• Harrington, L.E. et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6, 1123–1132 (2005).
  Article CAS Google Scholar
• Park, H. et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6, 1133–1141 (2005).
  Article CAS Google Scholar
• Nakae, S., Nambu, A., Sudo, K. & Iwakura, Y. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J. Immunol. 171, 6173–6177 (2003).
  Article CAS Google Scholar
• Langrish, C.L. et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201, 233–240 (2005).
  Article CAS Google Scholar
• Veldhoen, M., Hocking, R.J., Atkins, C.J., Locksley, R.M. & Stockinger, B. TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24, 179–189 (2006).
  Article CAS Google Scholar
• Gorelik, L. & Flavell, R.A. Abrogation of TGFβ signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity 12, 171–181 (2000).
  Article CAS Google Scholar
• Bettelli, E. et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441, 235–238 (2006).
  Article CAS Google Scholar
• Infante-Duarte, C., Horton, H.F., Byrne, M.C. & Kamradt, T. Microbial lipopeptides induce the production of IL-17 in Th cells. J. Immunol. 165, 6107–6115 (2000).
  Article CAS Google Scholar
• Khader, S.A. et al. IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-γ responses if IL-12p70 is available. J. Immunol. 175, 788–795 (2005).
  Article CAS Google Scholar
• Massague, J. The transforming growth factor-β family. Annu. Rev. Cell Biol. 6, 597–641 (1990).
  Article CAS Google Scholar
• Wahl, S.M., Allen, J.B., Costa, G.L., Wong, H.L. & Dasch, J.R. Reversal of acute and chronic synovial inflammation by anti-transforming growth factor β. J. Exp. Med. 177, 225–230 (1993).
  Article CAS Google Scholar
• Wahl, S.M. Transforming growth factor β: the good, the bad, and the ugly. J. Exp. Med. 180, 1587–1590 (1994).
  Article CAS Google Scholar
• Zhang, X. et al. Recovery from experimental allergic encephalomyelitis is TGF-β dependent and associated with increases in CD4+LAP+ and CD4+CD25+ T cells. Int. Immunol. 18, 495–503 (2006).
  Article CAS Google Scholar
• Szczepanik, M., Tutaj, M., Bryniarski, K. & Dittel, B.N. Epicutaneously induced TGF-β-dependent tolerance inhibits experimental autoimmune encephalomyelitis. J. Neuroimmunol. 164, 105–114 (2005).
  Article CAS Google Scholar
• Murano, M. et al. Latent TGF-β1-transduced CD4+ T cells suppress the progression of allergic encephalomyelitis. J. Leukoc. Biol. 79, 140–146 (2006).
  Article CAS Google Scholar
• Cautain, B. et al. Essential role of TGF-β in the natural resistance to experimental allergic encephalomyelitis in rats. Eur. J. Immunol. 31, 1132–1140 (2001).
  Article CAS Google Scholar
• Fahlen, L. et al. T cells that cannot respond to TGF-β escape control by CD4+CD25+ regulatory T cells. J. Exp. Med. 201, 737–746 (2005).
  Article CAS Google Scholar
• Yoshitomi, H. et al. A role for fungal β-glucans and their receptor Dectin-1 in the induction of autoimmune arthritis in genetically susceptible mice. J. Exp. Med. 201, 949–960 (2005).
  Article CAS Google Scholar
• Mangan, P.R. et al. Transforming growth factor-β induces development of the TH17 lineage. Nature 441, 231–234 (2006).
  Article CAS Google Scholar
• Cua, D.J. et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421, 744–748 (2003).
  Article CAS Google Scholar
• Chen, Y. et al. Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis. J. Clin. Invest. 116, 1317–1326 (2006).
  Article CAS Google Scholar
• Fontenot, J.D., Rasmussen, J.P., Gavin, M.A. & Rudensky, A.Y. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat. Immunol. 6, 1142–1151 (2005).
  Article CAS Google Scholar
• Zamvil, S. et al. T-cell clones specific for myelin basic protein induce chronic relapsing paralysis and demyelination. Nature 317, 355–358 (1985).
  Article CAS Google Scholar
• Martin, R., McFarland, H.F. & McFarlin, D.E. Immunological aspects of demyelinating diseases. Annu. Rev. Immunol. 10, 153–187 (1992).
  Article CAS Google Scholar
• Smith, S.B. & Waksman, B.H. Passive transfer and labelling studies on the cell infiltrate in experimental allergic encephalomyelitis. J. Pathol. 99, 237–244 (1969).
  Article CAS Google Scholar
• Lafaille, J.J. The role of helper T cell subsets in autoimmune diseases. Cytokine Growth Factor Rev. 9, 139–151 (1998).
  Article CAS Google Scholar
• Samoilova, E.B., Horton, J.L., Hilliard, B., Liu, T.S. & Chen, Y. IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: roles of IL-6 in the activation and differentiation of autoreactive T cells. J. Immunol. 161, 6480–6486 (1998).
  CAS PubMed Google Scholar
• Gijbels, K., Brocke, S., Abrams, J.S. & Steinman, L. Administration of neutralizing antibodies to interleukin-6 (IL-6) reduces experimental autoimmune encephalomyelitis and is associated with elevated levels of IL-6 bioactivity in central nervous system and circulation. Mol. Med. 1, 795–805 (1995).
  Article CAS Google Scholar
• Fossiez, F. et al. Interleukin-17. Int. Rev. Immunol. 16, 541–551 (1998).
  Article CAS Google Scholar
• Powell, M.B. et al. Lymphotoxin and tumor necrosis factor-α production by myelin basic protein-specific T cell clones correlates with encephalitogenicity. Int. Immunol. 2, 539–544 (1990).
  Article CAS Google Scholar
• Baker, D. et al. Control of established experimental allergic encephalomyelitis by inhibition of tumor necrosis factor (TNF) activity within the central nervous system using monoclonal antibodies and TNF receptor-immunoglobulin fusion proteins. Eur. J. Immunol. 24, 2040–2048 (1994).
  Article CAS Google Scholar
• Jovanovic, D.V. et al. IL-17 stimulates the production and expression of proinflammatory cytokines, IL-β and TNF-α, by human macrophages. J. Immunol. 160, 3513–3521 (1998).
  CAS PubMed Google Scholar
• Chabas, D. et al. The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science 294, 1731–1735 (2001).
  Article CAS Google Scholar
• Jansson, M., Panoutsakopoulou, V., Baker, J., Klein, L. & Cantor, H. Cutting edge: attenuated experimental autoimmune encephalomyelitis in eta-1/osteopontin-deficient mice. J. Immunol. 168, 2096–2099 (2002).
  Article CAS Google Scholar
• Ashkar, S. et al. Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science 287, 860–864 (2000).
  Article CAS Google Scholar
• Abel, B., Freigang, S., Bachmann, M.F., Boschert, U. & Kopf, M. Osteopontin is not required for the development of Th1 responses and viral immunity. J. Immunol. 175, 6006–6013 (2005).
  Article CAS Google Scholar
• da Silva, A.P. et al. Exacerbated tissue destruction in DSS-induced acute colitis of OPN-null mice is associated with downregulation of TNF-α expression and non-programmed cell death. J. Cell. Physiol. 208, 629–639 (2006).
  Article Google Scholar
• Lock, C. et al. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat. Med. 8, 500–508 (2002).
  Article CAS Google Scholar
• Fossiez, F. et al. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J. Exp. Med. 183, 2593–2603 (1996).
  Article CAS Google Scholar
• Komiyama, Y. et al. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol. 177, 566–573 (2006).
  Article CAS Google Scholar
• McKenzie, B.S., Kastelein, R.A. & Cua, D.J. Understanding the IL-23-IL-17 immune pathway. Trends Immunol. 27, 17–23 (2006).
  Article CAS Google Scholar
• Gantner, B.N., Simmons, R.M., Canavera, S.J., Akira, S. & Underhill, D.M. Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2. J. Exp. Med. 197, 1107–1117 (2003).
  Article CAS Google Scholar
• Dillon, S. et al. Yeast zymosan, a stimulus for TLR2 and dectin-1, induces regulatory antigen-presenting cells and immunological tolerance. J. Clin. Invest. 116, 916–928 (2006).
  Article CAS Google Scholar
• Du, Z. et al. Selective regulation of IL-10 signaling and function by zymosan. J. Immunol. 176, 4785–4792 (2006).
  Article CAS Google Scholar
• Riley, L.W. Of mice, men, and elephants: Mycobacterium tuberculosis cell envelope lipids and pathogenesis. J. Clin. Invest. 116, 1475–1478 (2006).
  Article CAS Google Scholar